Sysmex (OTCMKTS:SSMXY) Hits New 12-Month Low – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXY) reached a new 52-week low on Wednesday . The stock traded as low as $10.69 and last traded at $10.99, with a volume of 212436 shares changing hands. The stock had previously closed at $11.11.

Analyst Upgrades and Downgrades

SSMXY has been the topic of several analyst reports. The Goldman Sachs Group raised Sysmex from a “hold” rating to a “buy” rating in a research report on Thursday, October 9th. Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Sysmex has a consensus rating of “Moderate Buy”.

Sysmex Stock Down 1.1%

The company has a 50-day simple moving average of $12.29 and a 200 day simple moving average of $15.10. The company has a market cap of $6.92 billion, a P/E ratio of 21.98 and a beta of 1.16. The company has a current ratio of 3.37, a quick ratio of 2.49 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.07). Sysmex had a net margin of 9.35% and a return on equity of 10.20%. The business had revenue of $717.09 million during the quarter, compared to the consensus estimate of $807.27 million. On average, equities analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.